Acuvax, Biolife Science Ltd. deal

Biolife will reverse-merge with Acuvax in a stock deal. Acuvax will issue 20 million of its shares to Biolife up front. Acuvax will own 100% of

Read the full 260 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE